dsdsa

product

Fast delivery Doxorubicin Hcl - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Fast and fantastic quotations, informed advisers to help you choose the correct products that suits all your needs, a short manufacturing time, responsible good quality control and distinct companies for paying and shipping affairs for Cetilistat, Tadalafil Api, 1392275-56-7, For further inquires please do not hesitate to contact us. Thank you - Your support continuously inspires us.
Fast delivery Doxorubicin Hcl - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai Detail:

Product name Docetaxel Trihydrate
Synonyms (αR,βS)-β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-benzenepropanoic acid, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,hydrate (1:3)
CAS No. 148408-66-6
Appearance White to off-white crystalline powder
Molecular Formula C43H53NO14.3(H2O)
Molecular Weight 861.94
Application Pharma grade or research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Docetaxel Trihydrate CAS# 148408-66-6

ITEMS

STANDARDS

RESULTS

Characters A:White to off-white crystalline powder Conforms
B:Solubility :Insoluble in water ,soluble in ethanol and acetone   Conforms
Specific Rotation             ﹣38.5°~﹣41.5° ﹣40°
Identification 1.IR:  The same to check sample    Conforms
2.UV:  λmax232nm    Conforms
  1. Colour reactions: positive reactions
   Conforms
  1. HPLC: retention times is same as the standard sample
   Conforms
Impurities Total impurities: NMT 1.0% 0.29%
Impurities A: NMT 0.5% 0.0551%
Impurities B: NMT 0.3% 0.0470%
Impurities C: NMT 0.3% 0.0535%
Any other single impurity: NMT 0.1% 0.0702%
Water 5.0% – 7.0% 6.15%
Residue on ignition NMT 0.1% w/w 0.03%
Heavy metal NMT 20ppm Conforms
Assay 97.5%~ 102.0% 99.7%
Conclusion

It meets EP7.5.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Fast delivery Doxorubicin Hcl - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

Fast delivery Doxorubicin Hcl - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures

Fast delivery Doxorubicin Hcl - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai detail pictures


Related Product Guide:

We thinks what prospects think, the urgency of urgency to act from the interests of a client position of theory, allowing for greater high-quality, reduced processing costs, rates are much more reasonable, won the new and previous consumers the support and affirmation for Fast delivery Doxorubicin Hcl - USP EP BP Medicine Grade 148408-66-6 Docetaxel trihydrate for Treatment of Tumor Cancer – Yibai , The product will supply to all over the world, such as: Belgium, Libya, Portugal, We have been sincerely looking forward to cooperate with customers all over the world. We believe we can satisfy you with our high-quality products and solutions and perfect service . We also warmly welcome customers to visit our company and purchase our products.
  • The company account manager has a wealth of industry knowledge and experience, he could provide appropriate program according our needs and speak English fluently.
    5 Stars By Chris from Danish - 2017.03.07 13:42
    The product manager is a very hot and professional person, we have a pleasant conversation, and finally we reached a consensus agreement.
    5 Stars By Matthew from Japan - 2018.11.11 19:52
    Write your message here and send it to us